Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYCynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive ResultsPREV STORYAETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY